CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,634,700 | -48.2% | 60,000 | -57.1% | 0.03% | -31.6% |
| Q1 2022 | $3,154,000 | +71.7% | 140,000 | +50.9% | 0.04% | +81.0% |
| Q4 2021 | $1,837,000 | -42.4% | 92,800 | -30.7% | 0.02% | -69.1% |
| Q1 2021 | $3,189,000 | +633.1% | 134,000 | +436.0% | 0.07% | +580.0% |
| Q3 2020 | $435,000 | -63.1% | 25,000 | -64.3% | 0.01% | -75.0% |
| Q2 2020 | $1,180,000 | -20.6% | 70,000 | -44.0% | 0.04% | -51.8% |
| Q1 2020 | $1,487,000 | -21.7% | 125,000 | -20.3% | 0.08% | +29.7% |
| Q4 2019 | $1,898,000 | +41.9% | 156,900 | +30.8% | 0.06% | -3.0% |
| Q2 2019 | $1,338,000 | +142.8% | 120,000 | +155.9% | 0.07% | +120.0% |
| Q1 2019 | $551,000 | – | 46,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |